Vista AI, a U.S.-based medical imaging software company specializing in AI-powered MRI automation, has raised $29.5 million in Series B financing to accelerate its product roadmap and scale adoption across U.S. hospitals and imaging centers. The funding round, announced on January 14, 2026, includes strategic investments from leading health systems such as Cedars-Sinai Health System, […]
Illumina, Inc. has launched the Billion Cell Atlas, a large-scale genetic perturbation dataset designed to serve as foundational infrastructure for artificial intelligence-enabled drug discovery. Announced alongside strategic collaborations with AstraZeneca, Merck, and Eli Lilly and Company, the platform leverages CRISPR-based genome editing and single-cell RNA sequencing across more than 200 disease-relevant cell lines. This marks […]
Smith+Nephew has signed a definitive agreement to acquire Integrity Orthopaedics, a U.S.-based developer of the Tendon Seam rotator cuff repair system, in a deal worth up to $450 million. The move strengthens the medical device manufacturer’s presence in the sports medicine market by adding a novel repair platform designed to reduce re-tear rates, improve workflow […]
The U.S. Food and Drug Administration has granted 510(k) clearance to Singular Health Limited’s 3DICOM MD Cloud platform, expanding the Australian company’s regulated product portfolio in the United States. This marks the second FDA approval for the company’s medical imaging software line, following the clearance of its desktop-based 3DICOM MD Viewer in October 2022. The […]
Find out how 10x Genomics and Brigham & Women’s Hospital are using single-cell profiling to redefine autoimmune diagnostics. Can it change patient care?
Datasea unveils two acoustic-powered BCI innovations targeting rehab robotics and assistive communication. Find out what this means for the future of healthcare AI.
Medtronic’s MiniMed Go earns FDA clearance. Learn how it could reshape insulin injection therapy by combining smart pens, CGM insights, and dose algorithms.
Find out how 10x Genomics and Dana-Farber aim to transform cancer diagnostics using spatial biology and single cell profiling for real-world clinical decisions.